Cadent Therapeutics
ID: 5329507Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.
2
Funding Rounds
$80.0m
Money raised
Recent Funding Rounds
Overview
Cadent Therapeutics was a Cambridge, Massachusetts-based precision neuroscience company developing drugs for the treatment of psychiatric diseases The company was acquired by Novartis in December 2020.
- Business model: B2B
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding series
Funding Series Analysis
The company Cadent Therapeutics has raised a total of $40m in funding over 2 rounds.
Key Insights:
- Cadent Therapeutics Series B round, November 2018: $40m
- Cadent Therapeutics funding round, November 2018: $40m
Industries
Cadent Therapeutics is active in the following industries: